Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefepime Monotherapy vs Combination for CAPD Peritonitis
NCT02872038Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- Aug 2015
- Primary completion
- Nov 2016
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefepime in peritonitis, sponsored by Chulalongkorn University. Started Aug 2015; status: completed.
02
Drugs
cefepime
03
Conditions
peritonitis
Beyond the preview
Go deeper on NCT02872038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872038.